The U.S. Federal Trade Commission (FTC) has cleared the path for the sale of General Electric Co.’s (NYSE:GE) BioPharma unit to Danaher Corp. (NYSE:DHR). The deal was announced in February, 2019.

More GE and Danaher Get FTC Clearance for BioPharma Deal Videos